InterVenn Biosciences utilizes a proprietary high-throughput glycoproteomic interrogation platform using artificial intelligence and mass spectrometry for next-gen precision medicine. The company is working to find new solutions in ovarian, pancreatic, liver, prostate, and kidney cancer, together with applications from the Vista suite of solutions for treatment and monitoring, immune profiling, patient stratification, and disease progression.
South San Francisco, CA, USAintervenn.comInaccurate data? Flag it here.
Open jobs at InterVenn Biosciences
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.